ACB - Aurora Cannabis Inc.

NYSE - NYSE Delayed Price. Currency in USD
3.2900
-0.2600 (-7.32%)
At close: 4:00PM EST

2.9100 -0.38 (-11.55%)
After hours: 7:59PM EST

Stock chart is not supported by your current browser
Previous Close3.5500
Open3.4200
Bid2.9000 x 21500
Ask2.9100 x 42300
Day's Range3.1100 - 3.4300
52 Week Range3.1100 - 10.3200
Volume28,511,016
Avg. Volume14,804,044
Market Cap3.314B
Beta (3Y Monthly)1.97
PE Ratio (TTM)15.23
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Aurora Cannabis halts construction plans after miss in latest quarter
    Yahoo Finance Canada

    Aurora Cannabis halts construction plans after miss in latest quarter

    Aurora Cannabis has announced plans to shore up its balance sheet that include halting construction plans at facilities in Alberta and Denmark.

  • How this CBD company created a buzz by 'kind of making fun of millennial culture'
    Yahoo Finance

    How this CBD company created a buzz by 'kind of making fun of millennial culture'

    Ask Benjamin Witte about Recess, and one of the first places he’ll send you is the company’s Instagram page.

  • Why Marijuana Stocks Plummeted in 2019
    Zacks

    Why Marijuana Stocks Plummeted in 2019

    Marijuana stocks were on a tear last year, but 2019 has sent stock tumbling back down to Earth. What happened?

  • Aurora Cannabis Inc. (ACB) Q1 Earnings Surpass Estimates
    Zacks

    Aurora Cannabis Inc. (ACB) Q1 Earnings Surpass Estimates

    Aurora Cannabis Inc. (ACB) delivered earnings and revenue surprises of 133.33% and -21.69%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • The Canadian Press

    Most actively traded companies on the TSX

    TORONTO — Some of the most active companies traded Thursday on the Toronto Stock Exchange:Toronto Stock Exchange (16,972.18, up 14.19 points.)Aurora Cannabis Inc. (TSX:ACB). Health care. Down 31 cents, or 6.61 per cent, to $4.38 on 8.2 million shares.Manulife Financial Corp. (TSX:MFC). Financials. Unchanged at $26.26 on 7 million shares.Canopy Growth Corp. (TSX:WEED). Health care. Down $3.49 or 14.27 per cent, to $20.96 on 5.5 million shares.The Green Organic Dutchman Holdings. (TSX:TGOD). Health care. Down nine cents, or 9.78 per cent, to 83 cents on 5.5 million shares.Encana Corp. (TSX:ECA). Energy. Down 11 cents, or 1.88 per cent, to $5.75 on 4.7 million shares.Enbridge Inc. (TSX:ENB). Energy. Down $1.37 or 2.67 per cent, to $50.00 on 4 million shares. Companies in the news:Cineplex Inc. (TSX:CGX). Up $1.22 or 5.3 per cent to $24.32. Cineplex Inc. shares rose after the company reported record high revenue for its third quarter and outperformed analyst expectations, helped by a strong film slate including "The Lion King" and "Spider-Man: Far From Home." Cineplex reported Thursday that its third-quarter profit rose to $13.4 million from $10.2 million a year earlier. Revenue grew 8.3 per cent to a record $418.4 million as theatre attendance increased 1.8 per cent due to what Cineplex called a stronger film slate compared with last year. In addition to The Lion King and Spider-Man, Cineplex attributed the strength to films such as "Fast & Furious Presents: Hobbs & Shaw," "It Chapter Two" and "Once Upon a Time in Hollywood."Freshii Inc. (TSX:FRII). Down one cent to $2.70. Freshii Inc. continued to see traffic to its health-food eateries fall during its most recent quarter, but the company believes upcoming initiatives including a loyalty program can win over consumers. Same-store sales, a key retail metric, fell 3.7 per cent for the quarter ended Sept. 29. CEO Matthew Corrin said the company's current program, which focuses on offering limited-time menu items, isn't driving new traffic. Freshii's digital marketing campaigns and other initiatives expected to roll out next year will look to lure new customers into its stores, he said.Canopy Growth Corp. — Canopy Growth Corp.'s share price hit a 2019 low Thursday after the Canadian cannabis producer posted a $374.6-million quarterly loss, missed analyst revenue estimates and warned that a key revenue target may not be achieved. The company announced that second-quarter net revenue totalled $76.6 million, which was down 15 per cent from the prior quarter and below an average estimate of $107 million compiled by financial markets data firm Refinitiv. Interim chief executive Mark Zekulin also told analysts during a conference call that his previous projection of $250 million in revenue for the company's fourth quarter, ending in March, "is increasingly unlikely."Chorus Aviation Inc. (TSX:CHR). Up five cents to $8.20. Chorus Aviation Inc. reported a profit of $24.2 million in its latest quarter as revenue increased 2.8 per cent compared with a year ago. The regional aircraft company says the profit amounted to 15 cents per share for the quarter ended Sept. 30, weighed down by a $7.1-million loss on foreign exchange. The result compared with a profit of $43.6 million or 31 cents per share a year ago when it benefited from an $11.3-million gain on foreign exchange. Operating revenue totalled nearly $351.5 million, up from $342 million.This report by The Canadian Press was first published Nov. 14, 2019. The Canadian Press

  • 5 Must Watch Items as Aurora Cannabis (TSX:ACB) Reports Quarterly Earnings on Thursday
    The Motley Fool

    5 Must Watch Items as Aurora Cannabis (TSX:ACB) Reports Quarterly Earnings on Thursday

    The following items require special investor focus in the upcoming quarterly earnings of Aurora Cannabis (TSX:ACB)(NYSE:ACB).

  • 2 Marijuana Stocks I’d Buy on the Verge of an Industry Purge
    The Motley Fool

    2 Marijuana Stocks I’d Buy on the Verge of an Industry Purge

    Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) and another robust marijuana stock could still make you filthy rich.

  • What's in the Cards for Aurora Cannabis (ACB) in Q1 Earnings?
    Zacks

    What's in the Cards for Aurora Cannabis (ACB) in Q1 Earnings?

    Aurora Cannabis' (ACB) Q1 earnings are likely to reflect cannabis revenue growth and improved gross margin.

  • 5 Trendy Earnings Charts
    Zacks

    5 Trendy Earnings Charts

    Are cannabis and solar stocks still the place to be for traders in 2019?

  • What's in Store for Aurora Cannabis' (ACB) Q1 Earnings?
    Zacks

    What's in Store for Aurora Cannabis' (ACB) Q1 Earnings?

    Solid prospects in the Canadian and international markets are expected to have driven Aurora Cannabis' (ACB) fiscal first-quarter performance.

  • Don’t Give Up on These 2 Stocks Yet
    The Motley Fool

    Don’t Give Up on These 2 Stocks Yet

    Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) and BlackBerry Ltd. (TSX:BB)(NYSE:BB) look like promising comeback candidates ahead of 2020.

  • CBD beverage founder: 'I want to be regulated'
    Yahoo Finance

    CBD beverage founder: 'I want to be regulated'

    Not nearly enough legislative ink has been spilled over the booming CBD industry, according to Benjamin Witte. 

  • Kicking Aurora (TSX:ACB) When it’s Down Is Unwise
    The Motley Fool

    Kicking Aurora (TSX:ACB) When it’s Down Is Unwise

    Find out why Aurora can still be worth holding, even when its market value is consistently going down.

  • What's in Store for Radiant Logistics (RLGT) in Q1 Earnings?
    Zacks

    What's in Store for Radiant Logistics (RLGT) in Q1 Earnings?

    While a sluggish freight scenario is likely to affect Radiant Logistics' (RLGT) Q1 results, its higher revenues at the U.S. segment are expected to have aided the top line.

  • Aurora Cannabis (ACB) Q1 Earnings on Deck: Can Things Turnaround?
    Zacks

    Aurora Cannabis (ACB) Q1 Earnings on Deck: Can Things Turnaround?

    Aurora Cannabis (ACB) is set to report its first quarter results after the closing bell Thursday, November 14th.

  • ALERT: 1 Week Before Aurora Cannabis (TSX:ACB) Earnings
    The Motley Fool

    ALERT: 1 Week Before Aurora Cannabis (TSX:ACB) Earnings

    Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) is set to release earnings next week, as its stock nears a 52-week low.

  • U.S.-China Trade Progress, Q3 Earnings Results & Buy Yeti Stock - Free Lunch
    Zacks

    U.S.-China Trade Progress, Q3 Earnings Results & Buy Yeti Stock - Free Lunch

    The latest U.S.-China trade war news that could see the world's two largest economies roll back tariffs. Q3 earnings results from the likes of Qualcomm and Square. And why Yeti is a Zacks Rank 1 (Strong Buy) stock...

  • Aurora Cannabis Inc. (ACB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
    Zacks

    Aurora Cannabis Inc. (ACB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

    Aurora Cannabis Inc. (ACB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Former Canopy Growth CEO Bruce Linton joins US cannabis company's board, Vireo stock surges 35%
    Yahoo Finance

    Former Canopy Growth CEO Bruce Linton joins US cannabis company's board, Vireo stock surges 35%

    After parting ways with Canadian cannabis giant Canopy Growth, Bruce Linton is joining the board of U.S. multi-state operator Vireo Health.

  • Buy Cronos (CRON) Stock Ahead of Earnings as Bet on Marijuana Comeback?
    Zacks

    Buy Cronos (CRON) Stock Ahead of Earnings as Bet on Marijuana Comeback?

    Should investors think about buying some shares of Cronos (CRON) ahead of earnings, as a bet on a marijuana market comeback?

  • Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know
    Zacks

    Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know

    Aurora Cannabis Inc. (ACB) closed at $3.72 in the latest trading session, marking a -1.06% move from the prior day.

  • Does Aphria’s Valuation Look Attractive in November?
    Market Realist

    Does Aphria’s Valuation Look Attractive in November?

    Aphria’s stock price has risen 8.9% since reporting its Q1 earnings on October 15. The cannabis sector's weakness offset some of these gains.

  • Cronos Group Joins Altria to Bet on Cannabidiol Market
    Market Realist

    Cronos Group Joins Altria to Bet on Cannabidiol Market

    Cannabis company Cronos Group has expanded its presence in the US cannabidiol market through a tie-up with tobacco company Altria Group.